Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

10.25
-0.4200-3.94%
Post-market: 10.250.00000.00%16:31 EDT
Volume:1.31M
Turnover:13.45M
Market Cap:881.99M
PE:-2.66
High:10.58
Open:10.44
Low:10.05
Close:10.67
Loading ...

Syndax Pharmaceuticals (SNDX) Gets a Buy from Barclays

TIPRANKS
·
06 May

Syndax price target raised to $26 from $25 at BofA

TIPRANKS
·
06 May

Syndax Pharmaceuticals Inc : Scotiabank Raises Target Price to $17 From $16

THOMSON REUTERS
·
06 May

Promising Growth and Strategic Positioning Drive Buy Rating for Syndax Pharmaceuticals

TIPRANKS
·
06 May

Syndax Pharmaceuticals Q1 Loss Widens

MT Newswires Live
·
06 May

TD Cowen Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
06 May

Syndax Pharmaceuticals Reports Strong Q1 2025 Results

TIPRANKS
·
06 May

Syndax Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Syndax: Q1 Earnings Snapshot

Associated Press Finance
·
06 May

Syndax Pharmaceuticals Q1 EPS $(0.98) Beats $(1.03) Estimate, Sales $20.04M Beat $14.43M Estimate

Benzinga
·
06 May

BRIEF-Syndax Pharmaceuticals Q1 EPS USD -0.98

Reuters
·
06 May

Syndax Pharmaceuticals Q1 Operating Expenses USD 103.799 Million

THOMSON REUTERS
·
06 May

Syndax Pharmaceuticals Q1 Cash & Investments USD 602.1 Million

THOMSON REUTERS
·
06 May

Syndax Pharmaceuticals - Not Providing Revenue Guidance at This Time

THOMSON REUTERS
·
06 May

Syndax Pharmaceuticals Q1 EPS USD -0.98

THOMSON REUTERS
·
06 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 May

Syndax Pharmaceuticals Announce Inducement Grants for Seven New Employees Under 2023 Plan

Reuters
·
03 May

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
03 May

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

GlobeNewswire
·
28 Apr

BRIEF-Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
05 Apr